Malignant Pleural Mesothelioma - Alfacell Forms New Thoracic Cancer Advisory Board

Alfacell Forms New Thoracic Cancer Advisory Board
[Press Release] PR Newswire via Yahoo! Finance - Jan 27 6:32 AM
Alfacell Corporation today announced the formation of a Thoracic Cancer Advisory Board to support the Company's strategic focus on developing novel ribonuclease therapies for the treatment of diseases such as mesothelioma and non-small cell lung cancer .Save to My Web

Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says
Business Insurance - Jan 29 10:07 AM
LONDONOverturning a legal precedent of more than 20 years, the U.K. Court of Appeal last week ruled that anxiety induced by the asbestos-related condition pleural plaques should not be compensable.Save to My Web

LiLLY (ELI) & COMPANY: Lilly Reports 4th Qtr and 2005 Results
FinanzNachrichten - Feb 01 8:57 AM
Date: January 26, 2006 For Release: Immediately Refer to: (317) 276-5795 - Terra Fox Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges EPS Grew 16% in Q4 and 11% in 2005, Excluding Charges and Expensing Options Both Years Newer Products Represented 18% of Sales in 2005, compared with 11% in 2004 Eli Lilly ( Nachrichten / Aktienkurs ) and Save to My Web

Malignant Pleural Mesothelioma - Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...

Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...
DG News - Feb 3, 2006... maintenance therapy may provide substantial improvement in survival over existing therapies in patients with malignant pleural mesothelioma (MPM), according to ...

Early Chemotherapy Improves Outcomes for Mesothelioma
Cancer Consultants (press release), TN - Feb 9, 2006Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. ...

Malignant Pleural Mesothelioma - Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says

Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says
Business Insurance - Jan 29 10:07 AM
LONDONOverturning a legal precedent of more than 20 years, the U.K. Court of Appeal last week ruled that anxiety induced by the asbestos-related condition pleural plaques should not be compensable.Save to My Web

Alfacell Forms New Thoracic Cancer Advisory Board
RedNova - Jan 27 7:31 AM
BLOOMFIELD, N.J., Jan. 27 /PRNewswire-FirstCalSave to My Web

Malignant Pleural Mesothelioma - Alfacell Forms New Thoracic Cancer Advisory Board

Alfacell Forms New Thoracic Cancer Advisory Board
[Press Release] PR Newswire via Yahoo! Finance - Jan 27 6:32 AM
Alfacell Corporation today announced the formation of a Thoracic Cancer Advisory Board to support the Company's strategic focus on developing novel ribonuclease therapies for the treatment of diseases such as mesothelioma and non-small cell lung cancer .Save to My Web

Malignant Pleural Mesothelioma - Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PR Newswire (press release), NY - Jan 26, 2006... Alimta For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer ...

Malignant Pleural Mesothelioma - Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says

Lung scars rarely lead to asbestos-related diseases, U.K. appeals court says
Business Insurance - Jan 29 10:07 AM
LONDONOverturning a legal precedent of more than 20 years, the U.K. Court of Appeal last week ruled that anxiety induced by the asbestos-related condition pleural plaques should not be compensable.Save to My Web

Malignant Pleural Mesothelioma - Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PR Newswire (press release), NY - Jan 26, 2006... Alimta For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer ...

Malignant Pleural Mesothelioma - Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...

Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...
DG News - Feb 3, 2006... maintenance therapy may provide substantial improvement in survival over existing therapies in patients with malignant pleural mesothelioma (MPM), according to ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PharmaLive.com (press release), PA - Jan 26, 2006... For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer, generated sales ...

Mesothelioma Treatment 101
Only Idol, MS - Jan 26, 2006... In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma. ...

Malignant Pleural Mesothelioma - Early Chemotherapy Improves Outcomes for Mesothelioma

Early Chemotherapy Improves Outcomes for Mesothelioma
Cancer Consultants (press release), TN - Feb 9, 2006Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. ...

Malignant Pleural Mesothelioma - Alfacell Forms New Thoracic Cancer Advisory Board

Alfacell Forms New Thoracic Cancer Advisory Board
Yahoo! News (press release) - Jan 27, 2006... He has studied pleural mesothelioma since 1988 when he ... treatment and management of mesothelioma and lung ... registration study for malignant mesothelioma (MM) and ...

Interferon Alpha May Help Treat Malignant Pleural Mesothelioma ...
DG News - Feb 3, 2006... maintenance therapy may provide substantial improvement in survival over existing therapies in patients with malignant pleural mesothelioma (MPM), according to ...

Malignant Pleural Mesothelioma - Early Chemotherapy Improves Outcomes for Mesothelioma

Early Chemotherapy Improves Outcomes for Mesothelioma
Cancer Consultants (press release), TN - Feb 9, 2006Malignant pleural mesothelioma is a rare cancer that develops in the tissue that covers the lungs and lines the interior of the chest. ...

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ...
PR Newswire (press release), NY - Jan 26, 2006... Alimta For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer ...

Mesothelioma Treatment 101
Only Idol, MS - Jan 26, 2006... In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma. ...

Malignant Pleural Mesothelioma - Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
FinanzNachrichten - Jan 26 3:39 AM
INDIANAPOLIS, Jan. 26 /PRNewswire-FirstCall/ -- Eli Lilly ( Nachrichten / Aktienkurs ) and Company today announced financial results for the fourth quarter and full year of 2005.Save to My Web

LiLLY (ELI) & COMPANY: Lilly Reports 4th Qtr and 2005 Results
FinanzNachrichten - Feb 01 8:57 AM
Date: January 26, 2006 For Release: Immediately Refer to: (317) 276-5795 - Terra Fox Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges EPS Grew 16% in Q4 and 11% in 2005, Excluding Charges and Expensing Options Both Years Newer Products Represented 18% of Sales in 2005, compared with 11% in 2004 Eli Lilly ( Nachrichten / Aktienkurs ) and Save to My Web

Alfacell Forms New Thoracic Cancer Advisory Board
RedNova - Jan 27 7:31 AM
BLOOMFIELD, N.J., Jan. 27 /PRNewswire-FirstCalSave to My Web